March 15, 2018
FDA Grants Abeona Therapeutics Rare Pediatric Disease Designation for Batten Disease Gene Therapy
Read More
May 14, 2017
Abeona Therapeutics Receives Regulatory Approval to Initiate Clinical Trial in Australia with ABO-102 Gene Therapy For Patients with MPS IIIA
Read More
April 13, 2017
Register Now for the Cell and Gene Exchange!
Read More
March 1, 2017
Abeona Therapeutics Inc. Rings Closing Bell at Nasdaq on World Rare Disease Day
Read More
January 7, 2017
Abeona Therapeutics Receives Orphan Drug Designation in The European Union for ABO-201 Gene Therapy Program in Juvenile Batten Disease
Read More
October 21, 2016
RARECast: Abeona Advancing Pipeline of Gene Therapies for Rare Diseases
Read More
October 10, 2016
Abeona Therapeutics Authorized to Move Forward with Clinical Trial for Sanfilippo Syndrome Treatment
Read More
September 6, 2016
Rally on Rainier: Father Climbs For His Son and All Children Impacted by Sanfilippo Syndrome
Read More
August 15, 2016
Abeona Therapeutics, EB Research Partnership and EB Medical Research Foundation to Collaborate on Epidermolysis Bullosa (EB) Treatments
Read More
May 28, 2016
Abeona Therapeutics Doses First Patient in Phase 1/2 Trial With ABO-102 Gene Therapy for Patients With Sanfilippo Syndrome Type A (MPS IIIA)
Read More
October 18, 2015
Reasons To Gather: Michelle Berg of Abeona Shares Her Gala and Summit Experience
Read More
September 11, 2015
RARECast: Addressing Life-Threatening Rare Diseases with Gene Therapy
Read More
Load More
X